Answers are grounded in this paper and cite their sources.
Liposomal amphotericin B is as effective as conventional amphotericin B for empirical antifungal therapy in patients with fever and neutropenia, and it is associated with fewer breakthrough fungal infections, less infusion-related toxicity, and less nephrotoxicity.
No takes yet. Share an insight, caveat, or question.
Walsh et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: